Mannose-binding lectin deficiency in respiratory diseases
https://doi.org/10.18093/0869-0189-2016-26-6-748-752
Abstract
Mannosebinding lectin is a part of the innate immunity that, being the first barrier of the antiinfectious defense, acts in first minutes or hours after pathogen challenge. The review provides data about mechanisms of action of mannosebinding lectin and its particular pathogenic role in a wide range of respiratory diseases: bacterial pneumonia, viral respiratory tract infections, tuberculosis, cystic fibrosis, chronic obstructive pulmonary disease, and asthma in adults and children.
About the Authors
S. Yu. TereshchenkoRussian Federation
ul. Partizana Zheleznyaka 3G, Krasnoyarsk, 660022, Russia
Doctor of Medicine, Professor, Head of Division of Children's Somatic and Psychiatric Health, Federal Research Institute of Medical Problems of the North; tel.: (391) 2280683
E. V. Kasparov
Russian Federation
ul. Partizana Zheleznyaka 3G, Krasnoyarsk, 660022, Russia
Doctor of Medicine, Professor, Alternative Director of Federal Research Institute of Medical Problems of the North; tel.: (391)2280683
M. V. Smol'nikova
Russian Federation
ul. Partizana Zheleznyaka 3G, Krasnoyarsk, 660022, Russia
Candidate of Medicine, Leading Researcher at Laboratory of Molecular Physiology and Pathology, Federal Research Institute of Medical Problems of the North; tel.: (391) 2280683
E. V. Kuvshinova
Russian Federation
ul. Partizana Zheleznyaka 3G, Krasnoyarsk, 660022, Russia
Physician at Department of Pediatric Pulmonology, Federal Research Institute of Medical Problems of the North; tel.: (391) 2280683
References
1. Eisen D.P., Dean M.M., Boermeester M.A. et al. Low serum mannosebinding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis. 2008; 47 (4): 510–516. DOI: 10.1086/590006.
2. Rantala A., Lajunen T., Juvonen R. et al. Mannosebinding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J. Infect. Dis. 2008; 198 (8): 1247–1253.
3. Lundbo L.F., Harboe Z.B., Clausen L.N. et al. Mannose binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children. Clin. Infect. Dis. 2014; 59 (4): e66–71.
4. Eisen D.P., Stubbs J., Spilsbury D. et al. Low mannose binding lectin complement activation function is associated with predisposition to Legionnaires' disease. Clin. Exp. Immunol. 2007; 149 (1): 97–102.
5. Hamvas R.M., Johnson M., Vlieger A.M. et al. Role for mannose binding lectin in the prevention of Mycoplasma infection. Infect. Immun. 2005; 73 (8): 5238–5240.
6. Eisen D.P. Mannosebinding lectin deficiency and respiratory tract infection. J. Innate Immun. 2010; 2 (2): 114–122. DOI: 10.1159/000228159.
7. GarciaLaorden M. I., Pena M. J., Caminero J. A. et al. Influence of mannosebinding lectin on HIV infection and tuberculosis in a WesternEuropean population. Mol. Immunol. 2006; 43 (14): 2143–2150.
8. HoalVan Helden E.G., Epstein J., Victor T.C. et al. Man nosebinding protein B allele confers protection against tuberculous meningitis. Pediatr. Res. 1999; 45 (4, Pt 1): 459–464.
9. Bellamy R., Ruwende C., Mcadam K. P. et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM. 1998; 91 (1): 13–18.
10. Soborg C., Madsen H.O., Andersen A.B. et al. Mannose binding lectin polymorphisms in clinical tuberculosis. J. Infect. Dis. 2003; 188 (5): 777–782.
11. Hijikata M., Matsushita I., Hang N.T. et al. Agedependent association of mannosebinding lectin polymorphisms with the development of pulmonary tuberculosis in Viet Nam. Hum. Immunol. 2014; 75 (8): 840–846.
12. Chalmers J.D., Matsushita M., Kilpatrick D.C., Hill A.T. No Strong relationship between components of the lectin pathway of complement and susceptibility to pulmonary tuberculosis. Inflammation. 2015; 38 (4): 1731–1737.
13. Ribeiro L.Z., Tripp R.A., Rossi L.M. et al. Serum mannose binding lectin levels are linked with respiratory syncytial virus (RSV) disease. J. Clin. Immunol. 2008; 28 (2): 166–173.
14. Zhang H., Zhou G., Zhi L. et al. Association between man nosebinding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J. Infect. Dis. 2005; 192 (8): 1355–1361.
15. Tang Y.W., Li H., Wu H. et al. Host singlenucleotide polymorphisms and altered responses to inactivated influenza vaccine. J. Infect. Dis. 2007; 196 (7): 1021–1025.
16. Rashidi E., Fazlollahi M.R., Zahedifard S. et al. Mannose binding lectin deficiency in patients with a history of recur rent infections. Iran J. Allergy Asthma Immunol. 2016; 15 (1): 69–74.
17. Holdaway J., Deacock S., Williams P., Karim Y. Mannose binding lectin deficiency and predisposition to recurrent infection in adults. J. Clin. Pathol. 2016; 69: 731–736. DOI: 10.1136/jclinpath2015203065.
18. Crosdale D.J., Poulton K.V., Ollier W.E. et al. Mannose binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J. Infect. Dis. 2001; 184 (5): 653–656.
19. Granell M., UrbanoIspizua A., Suarez B. et al. Mannan binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp. Hematol. 2006; 34 (10): 1435–1441.
20. Esposito S., Ierardi V., Daleno C. et al. Genetic polymor phisms and risk of recurrent wheezing in pediatric age. BMC Pulm. Med. 2014; 14: 162. DOI: 10.1186/1471246614162.
21. Nuolivirta K., He Q., GrondahlYliHannuksela K. et al. Mannosebinding lectin gene polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing. Allergol. Int. 2012; 61 (2): 305–309.
22. Koponen P., He Q., Helminen M. et al. Association of MBL2 polymorphism with asthma after bronchiolitis in infancy. Pediatr. Int. 2012; 54 (5): 619–622.
23. Carrera M.C., Moura P., Crovella S. et al. High polymorphism of the MBL2 gene in patients with atopic dermatitis. Ann. Allergy Asthma Immunol. 2010; 105 (1): 39–42.
24. Leung T.F., Tang N.L., Sung Y.M. et al. Genetic association study between mbl2 and asthma phenotypes in Chinese children. Pediatr. Allergy Immunol. 2006; 17 (7): 501–507.
25. Bae S.J., Kim S.H., Losol P. et al. Mannosebinding lectin 2 gene polymorphisms affect serum mannosebinding lectin levels in adult asthmatics. Ann. Allergy Asthma. Immunol. 2013; 111 (1): 71–73.
26. Birbian N., Singh J., Jindal S. K. et al. Association of the wildtype A/A genotype of MBL2 codon 54 with asthma in a North Indian population. Dis. Markers. 2012; 32 (5): 301–308.
27. Aittoniemi J., Soranummi H., Rovio A.T. et al. Mannose binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin. Exp. Immunol. 2005; 142 (1): 120–124.
28. Heitzeneder S., Seidel M., ForsterWaldl E., Heitger A. Mannanbinding lectin deficiency – Good news, bad news, doesn't matter? Clin. Immunol. 2012; 143 (1): 22–38.
Review
For citations:
Tereshchenko S.Yu., Kasparov E.V., Smol'nikova M.V., Kuvshinova E.V. Mannose-binding lectin deficiency in respiratory diseases. PULMONOLOGIYA. 2016;26(6):748-752. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-6-748-752